NOXOPHARM LIMITED — Capital/Financing Update 2017

Aug 20, 2017

==> picture [180 x 76] intentionally omitted <==

Date: 21 August 2017 Sydney, Australia

Ms Cheng Tang Senior Adviser, Listings Compliance (Melbourne) ASX Compliance Pty Limited Level 4, Rialto North Tower 525 Collins Street Melbourne VIC 3000

By Email: cheng.tang@asx.com.au tradinghaltsmelbourne@asx.com.au

ASX: NOX

Noxopharm Limited

ABN 50 608 966 123

Registered Office:

Suite 1 Level 6 50 Queen St Melbourne VIC 3000 Australia

NOXOPHARM LIMITED – REQUEST FOR TRADING HALT

The Company requests an immediate trading halt in the securities of Noxopharm Limited (ASX:NOX) pending the release of an ASX announcement regarding a proposed capital raising. It is expected the trading halt will end on the earlier of the commencement of normal trading on Wednesday 23 August 2017, or when the announcement on the capital raising is released to the market.

The Company is not aware of any reason why the trading halt should not be granted.

Operational Office: Suite 3, Level 4 828 Pacific Highway Gordon NSW 2072 Australia

Board of Directors Mr Peter Marks Chairman Non-Executive Director

Thank you for your assistance.

Dr Graham Kelly Chief Executive Officer Managing Director

Yours faithfully,

==> picture [117 x 50] intentionally omitted <==

Dr Ian Dixon Non-Executive Director

David Franks Company Secretary